{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T22:11:32Z","timestamp":1700950292129},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00106-022-01201-w","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T11:04:19Z","timestamp":1660734259000},"page":"705-714","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperatives Gerinnungsmanagement in der HNO-Heilkunde","Perioperative management of coagulation in otorhinolaryngologic surgery"],"prefix":"10.1007","volume":"70","author":[{"given":"F.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"R\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Strieth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Send","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-56468-4","volume-title":"Physiologie des Menschen","author":"R Brandes","year":"2019","unstructured":"Brandes\u00a0R, Lang\u00a0F, Schmidt\u00a0RF (2019) Physiologie des Menschen, 32.\u00a0Aufl. Springer, Heidelberg","edition":"32"},{"key":"1201_CR2","unstructured":"Amboss Blutstillung und Blutgerinnung. https:\/\/www.amboss.com\/de\/wissen\/Blutstillung_und_Blutgerinnung;. Zugegriffen: 11. Jan. 2022"},{"key":"1201_CR3","unstructured":"(2015) AWMF Leitlinie online: Venenthrombose und Lungenembolie: Diagnostik und Therapie. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/065-002l_S2k_VTE_2016-01.pdf; (Erstellt: 10.2015). Zugegriffen: 11. Jan. 2022"},{"key":"1201_CR4","unstructured":"(2019) AWMF Leitlinie chronische KHK 5.\u00a0Auflage. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/nvl-004l_S3_KHK_2019-04.pdf;. Zugegriffen: 11. Jan. 2021"},{"key":"1201_CR5","unstructured":"Arzneimittelfachinformationen der Hersteller"},{"issue":"S 01","key":"1201_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-0034-1396872","volume":"94","author":"H Thiele","year":"2015","unstructured":"Thiele\u00a0H, Kaftan\u00a0H, Hosemann\u00a0W et al (2015) Perioperatives H\u00e4mostasemanagement bei HNO-Eingriffen. Laryngorhinootologie 94(S 01):143\u2013152","journal-title":"Laryngorhinootologie"},{"key":"1201_CR7","first-page":"271","volume":"21","author":"PR Issing","year":"2019","unstructured":"Issing\u00a0PR, Erath\u00a0B, Issing\u00a0C (2019) Aspirin, Marcumar, Pradaxa & Co. \u2013 was der HNO-Arzt \u00fcber Gerinnung und Thrombose wissen sollte. Forum HNO 21:271\u2013281","journal-title":"Forum HNO"},{"key":"1201_CR8","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.113.005754","volume":"129","author":"MW Sherwood","year":"2014","unstructured":"Sherwood\u00a0MW, Douketis\u00a0JD, Patel\u00a0MR et\u00a0al (2014) Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular artrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trail in atrial fibrillation (ROCKET AF). Circulation 129:1850\u20131859","journal-title":"Circulation"},{"key":"1201_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","volume":"89","author":"SC Cannegieter","year":"1994","unstructured":"Cannegieter\u00a0SC, Rosendaal\u00a0FR, Briet\u00a0E (1994) Thromboembolic and bleeding complications in patients with machanical heart valve protheses. Circulation 89:635\u2013641","journal-title":"Circulation"},{"key":"1201_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/107602960401000301","volume":"10","author":"J Koscielny","year":"2014","unstructured":"Koscielny\u00a0J, Ziemer\u00a0S, Radke\u00a0H et\u00a0al (2014) A practical concept for preoperative identification of patients with impaired pimary hemostasis. Clin Appl Thromb Hemost 10:195\u2013204","journal-title":"Clin Appl Thromb Hemost"},{"issue":"24","key":"1201_CR11","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1182\/blood-2012-05-423228","volume":"120","author":"TL Ortel","year":"2012","unstructured":"Ortel\u00a0TL (2012) Perioperative management of patients on chronic antithrombotic therapy. Blood 120(24):4699\u20134705","journal-title":"Blood"},{"key":"1201_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0194-5998(98)70268-2","volume":"118","author":"EH Moreano","year":"1998","unstructured":"Moreano\u00a0EH, Hutchison\u00a0JL, McCulloch\u00a0TM (1998) Incidence of venous thrombosis and pulmonary embolism in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg 118:777\u2013784","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1201_CR13","first-page":"21","volume":"139","author":"FG Garritano","year":"2013","unstructured":"Garritano\u00a0FG, Lehmann\u00a0EB, Andrews\u00a0GA (2013) Incidence of venous thromboembolism in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg 139:21\u201327","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1201_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaoto.2013.1049","volume":"139","author":"D Clayburgh","year":"2013","unstructured":"Clayburgh\u00a0D, Scott\u00a0W, Cordiero\u00a0T et\u00a0al (2013) Prospective study of venous thromboembolism in patients with head and neck cancer after surgery: interim analysis. JAMA Otolaryngol Head Neck Surg 139:21\u201327","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1201_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","volume":"370","author":"PJ Deveraux","year":"2014","unstructured":"Deveraux\u00a0PJ, Mrkobrada\u00a0M, Sessler\u00a0DJ et\u00a0al (2014) Aspirin in patients undergoing noncardiac surgery. N\u00a0Engl J Med 370:1494\u20131509","journal-title":"N Engl J Med"},{"key":"1201_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1538-7836.2012.04641.x","volume":"10","author":"C Li","year":"2012","unstructured":"Li\u00a0C, Hirsh\u00a0J, Xie\u00a0C et al (2012) Reversal of the anti-platelet effects of aspirin and clopidogrel. J\u00a0Thromb Haemost 10:521\u2013528","journal-title":"J Thromb Haemost"},{"key":"1201_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp337","author":"Task Force for Preoperative Cardiac Risk Assesment and Perioperative Cardiac Management in Non-cardiac Surgery, European Society of Cardiology (ESC)","year":"2009","unstructured":"Task Force for Preoperative Cardiac Risk Assesment and Perioperative Cardiac Management in Non-cardiac Surgery, European Society of Cardiology (ESC). (2009) ESC\/ESA Guidelines for pre-operative cardiac risk assesment and perioperative cardiac management in non-cardiac surgery. Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehp337","journal-title":"Eur Heart\u00a0J"},{"key":"1201_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/bja\/ael318","volume":"89","author":"L Broad","year":"2007","unstructured":"Broad\u00a0L, Lee\u00a0T, Conroy\u00a0M et al (2007) Successful management of patients with drug eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 89:19\u201322","journal-title":"Br J Anaesth"},{"key":"1201_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1213\/ane.0b013e3181731e95","volume":"107","author":"LT Newsome","year":"2008","unstructured":"Newsome\u00a0LT, Weller\u00a0RS, Gerancher\u00a0JC et\u00a0al (2008) Coronary artery stents: II. Perioperative considerations and management. Anesth Analg 107:570\u2013590","journal-title":"Anesth Analg"},{"key":"1201_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00106-014-2843-3","volume":"62","author":"A Knopf","year":"2014","unstructured":"Knopf\u00a0A, Freudelsperger\u00a0L, Stark\u00a0T et\u00a0al (2014) ENT surgery in patients with anticoagulants and platelet aggregation inhibitors. HNO 62:350\u2013357","journal-title":"HNO"},{"key":"1201_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22210","author":"T Send","year":"2019","unstructured":"Send T, Bertlich M, Horlbeck F et\u00a0al (2019) Management and outcome of epistaxis under direct oral anticoagulants: a\u00a0comparison with warfarin. Int Forum Allergy Rhinol. https:\/\/doi.org\/10.1002\/alr.22210","journal-title":"Int Forum Allergy Rhinol."},{"issue":"9","key":"1201_CR22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/PEC.0000000000001698","volume":"37","author":"T Send","year":"2021","unstructured":"Send\u00a0T, Bertlich\u00a0M, Eichhorn\u00a0KW et\u00a0al (2021) Etiology, management, and outcome of pediatric epistaxis. Pediatr Emerg Care 37(9):466\u2013470","journal-title":"Pediatr Emerg Care"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-022-01201-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-022-01201-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-022-01201-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T21:41:09Z","timestamp":1700948469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-022-01201-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1007\/s00106-022-01201-w","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"7 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>F.\u00a0Stahl<\/b>: A.\u00a0Finanzielle Interessen: F.\u00a0Stahl gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Assistenz\u00e4rztin in der Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde des Universit\u00e4tsklinikums Bonn. <b>H.\u00a0R\u00fchl<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar: med update, MTE Academy | Kostenerstattung: CSL Behring, SOBI, Bayer, Shire, Sanofi Genzyme, Grifols.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztlicher Leiter, MVZ Venusberg GmbH, Bonn | Gesch\u00e4ftsf\u00fchrender Oberarzt, Institut f\u00fcr Experimentelle H\u00e4matologie und Transfusionsmedizin, Universit\u00e4tsklinikum Bonn | Mitgliedschaften: DGTI (Obmann der Sektion \u201eH\u00e4mostaseologie\u201c), GTH, ASH, ISBT. <b>G.\u00a0Goldmann<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar: Biotest, Sobi, CSL Behring, Octapharma, Takeda, Bayer, Grifols, Biomarin, Novo Nordisk | Kostenerstattung: Novo Nordisk, CSL Behring, SOBI, Bayer, Takeda, Biotest. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Institut f\u00fcr Experimentelle H\u00e4matologie und Transfusionsmedizin, Universit\u00e4tsklinikum Bonn | Mitgliedschaften: BDDH Vorstandsmitglied. <b>S.\u00a0Strieth<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: DFG.\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: MED-EL. \u2013\u00a0Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00e4.: Merck, Sanofi.\u00a0\u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00e4. an einer im Medizinbereich aktiven Firma: BioNTech, Gilead. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellter HNO-Facharzt, Klinikdirektor Universit\u00e4tsklinikum Bonn (UKB), Universit\u00e4tsprofessor, Universit\u00e4t Bonn | Mitgliedschaften: DGHNO, DEGUM, DGAKI, ADANO, DGA. <b>T.\u00a0Send<\/b>: A.\u00a0Finanzielle Interessen: T.\u00a0Send gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: OA HNO UK Bonn | Mitgliedschaften: DG HNO, DG DGSC, DG PWC.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung aufExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}